Mention in the "Motley Fool"
The first stock is a small and diversified biotechnology company named ADMEDUS FPO (ASX: AHZ). At $0.125 per share, it has grown by more than 330% in the past year alone, but recently traded as high as $0.19. I’ve put the retraction in its share price down to the market’s impatience. It is currently forecast to realise its first (minor) profit in FY15.
However with its CardioCel technology, which is now available for sale in the United States, revenues and earnings can be expected to grow well into the future and opportunities for the technology seem endless. Currently Baillieu Holst Research and Morgans have price targets of $0.25 and $0.23 on the company respectively. For once, I agree with them.
Full article:
http://www.fool.com.au/2014/05/07/3-stocks-up-over-200-in-a-year/
sales orders for the us , page-50
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |